Logo
News
Feb 01, 2026

YiPSCELL and Paean Bio sign agreement to develop mitochondrial regenerative medicine

YiPSCELL and Paean Bio sign agreement to develop mitochondrial regenerative medicine
13 views
Share:

Related News

More Updates From Our Research Journey

News Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Feb 01, 2026

Source: http://m.biospectator.com/view/news_view.php?varAtcId=8243

Read More
News [Promising Company] Paean Biotechnology embarks on world's first mitochondrial clinical trial

[Promising Company] Paean Biotechnology embarks on world's first mitochondrial clinical trial

Feb 01, 2026

Source: https://www.hankyung.com/it/article/202112071993i

Read More
News World's first clinical trial for mitochondrial therapeutic... From immune cell therapy to anticancer drugs

World's first clinical trial for mitochondrial therapeutic... From immune cell therapy to anticancer drugs

Feb 01, 2026

Source: https://www.hankyung.com/it/article/202110202008i

Read More
News Paean Bio "Discussing CMO contract for European clinical trials"

Paean Bio "Discussing CMO contract for European clinical trials"

Feb 01, 2026

Source: https://www.hankyung.com/article/202112071993i

Read More
Logo

Headquarter : 108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea

Mail : info@paeanbio.com

Phone : 042-334-7378 | Fax : 042-334-7096

Navigation

Other

Copyrights © 2025 All Rights Reserved by PAEAN BIOTECHNOLOGY